Overview

Study of the Efficacy of Cloderm® Cream in the Treatment of Moderate Plaque Psoriasis

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Cloderm Cream is effective for topical treatment of moderate psoriasis over 28 days.
Phase:
Phase 4
Details
Lead Sponsor:
Promius Pharma, LLC
Treatments:
Clocortolone
Clocortolone pivalate
Fluocortolone